Afuco™ Anti-Human IFNL1 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-IFNL1 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The complexes of interferon-λ with an antibody or antigen-binding antibody fragment are more efficacious for treatment of cancer, asthma, Alzheimer's disease, multiple sclerosis or viral infection than interferon-λ alone, antibody alone, or the combination of unconjugated interferon-λ and antibody.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-366CL |
| Pricing | Inquiry |
| Host | Human |
| Target | IFNL1 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples. |